Epidermal Growth Factor Receptor (EGFR) Cell Expression During Adjuvant Treatment After Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A New Potential Tool to Identify Patients at Higher Risk of Disease Progression
- Autori: Di Maida, Fabrizio; Mari, Andrea; Scalici Gesolfo, Cristina; Cangemi, Antonina; Allegro, Rosalinda; Sforza, Simone; Cocci, Andrea; Tellini, Riccardo; Masieri, Lorenzo; Russo, Antonio; Carini, Marco; Minervini, Andrea; Serretta, Vincenzo
- Anno di pubblicazione: 2019
- Tipologia: Articolo in rivista (Articolo in rivista)
- OA Link: http://hdl.handle.net/10447/359492
Abstract
The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.